← All drugs
Drug

Choriogonadotropin Alfa

66 flagged reaction(s) · 1,803 total co-reports · max PRR 68.2
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Product Packaging Quantity Issue 83 68.2 70.7 signal
2 Poor Quality Product Administered 39 34.1 34.7 signal
3 Ascites 90 27.3 28.4 signal
4 Ovarian Cyst 21 18.6 18.8 signal
5 Abortion Spontaneous 73 16.2 16.7 signal
6 Product Availability Issue 35 13.9 14.1 signal
7 Abdominal Pain Lower 37 13.0 13.2 signal
8 Abortion Induced 13 12.3 12.4 signal
9 Circumstance Or Information Capable Of Leading To Medication Error 43 11.4 11.6 signal
10 Incorrect Route Of Product Administration 21 11.1 11.2 signal
11 Drug Level Decreased 12 10.5 10.5 signal
12 No Adverse Event 208 10.5 11.4 signal
13 Inappropriate Schedule Of Drug Administration 83 10.3 10.6 signal
14 Product Dose Omission 74 10.0 10.3 signal
15 Pelvic Pain 20 9.8 9.9 signal
16 Caesarean Section 12 9.1 9.1 signal
17 Abdominal Distension 100 8.6 8.9 signal
18 Pleural Effusion 53 7.8 7.9 signal
19 Drug Exposure During Pregnancy 29 7.5 7.6 signal
20 Product Packaging Issue 7 6.7 6.7 signal
21 Pregnancy 15 6.6 6.6 signal
22 Generalised Tonic-clonic Seizure 12 6.5 6.6 signal
23 Hyperthyroidism 9 5.5 5.6 signal
24 Maternal Exposure During Pregnancy 53 5.4 5.5 signal
25 Needle Issue 17 5.3 5.3 signal
26 Product Quality Issue 80 5.3 5.4 signal
27 Premature Baby 17 5.0 5.0 signal
28 Product Physical Issue 11 4.9 4.9 signal
29 Incorrect Product Storage 7 4.7 4.7 signal
30 Hepatic Cytolysis 6 4.4 4.4 signal
31 Vaginal Haemorrhage 20 4.2 4.2 signal
32 Hunger 6 4.0 4.0 signal
33 Product Prescribing Issue 9 3.9 4.0 signal
34 Circulatory Collapse 7 3.6 3.7 signal
35 Vaginal Discharge 4 3.5 3.6 signal
36 Injury Associated With Device 8 3.5 3.6 signal
37 Product Dose Omission Issue 110 3.4 3.6 signal
38 Product Preparation Error 8 3.4 3.4 signal
39 Premature Delivery 6 3.3 3.3 signal
40 Injection Site Urticaria 9 3.3 3.3 signal
41 Product Storage Error 30 3.1 3.1 signal
42 Injection Site Irritation 4 2.8 2.8 no signal
43 Foetal Exposure During Pregnancy 25 2.7 2.8 signal
44 Adverse Reaction 4 2.7 2.7 no signal
45 Injection Site Reaction 20 2.6 2.6 signal
46 Peritonitis 6 2.6 2.6 signal
47 Metrorrhagia 5 2.6 2.6 no signal
48 Cardiovascular Disorder 7 2.4 2.4 signal
49 Injection Site Mass 10 2.4 2.4 signal
50 Injection Site Pruritus 18 2.4 2.4 signal
51 Exposure During Pregnancy 16 2.3 2.3 signal
52 Mood Swings 8 2.2 2.2 signal
53 Libido Decreased 3 2.2 2.2 no signal
54 Exposure Via Skin Contact 5 2.0 2.0 no signal
55 Injection Site Pain 62 1.8 1.8 no signal
56 Injection Site Rash 6 1.8 1.8 no signal
57 Injection Site Warmth 4 1.7 1.7 no signal
58 Drug Dose Omission 32 1.7 1.7 no signal
59 Injection Site Bruising 12 1.4 1.4 no signal
60 Injection Site Erythema 18 1.3 1.3 no signal
61 Injection Site Swelling 11 1.3 1.3 no signal
62 Incorrect Route Of Drug Administration 5 1.2 1.2 no signal
63 Drug Effective For Unapproved Indication 4 1.2 1.2 no signal
64 Dermatitis Atopic 5 0.9 0.9 no signal
65 Accidental Exposure To Product 9 0.8 0.8 no signal
66 Injection Site Haemorrhage 7 0.8 0.8 no signal